The DOI matches its Crossref record; 195 of the 195 references it cites were found in a registry or an index.
Transferrin/transferrin receptor‐mediated drug delivery
Abstract
Since transferrin was discovered more than half a century ago, a considerable effort has been made towards understanding tranferrin‐mediated iron uptake. However, it was not until recently with the identification and characterization of several new genes related to iron homeostasis, such as the hemochromatosis protein HFE and the iron transporter DMT1, that our knowledge has been advanced dramatically. A major pathway for cellular iron uptake is through internalization of the complex of iron‐bound transferrin and the transferrin receptor, which is negatively modulated by HFE, a protein related to hereditary hemochromatosis. Iron is released from transferrin as the result of the acidic pH in endosome and then is transported to the cytosol by DMT1. The iron is then utilized as a cofactor by heme and ribonucleotide reductase or stored in ferritin. Apart from iron, many other metal ions of therapeutic and diagnostic interests can also bind to transferrin at the iron sites and their transferrin complexes can be recognized by many cells. Therefore, transferrin has been thought as a “delivery system” for many beneficial and harmful metal ions into the cells. Transferrin has also be widely applied as a targeting ligand in the active targeting of anticancer agents, proteins, and genes to primary proliferating malignant cells that overexpress transferrin receptors. This is achieved by conjugation of transferrin with drugs, proteins, hybride systems with marcomolecules and as liposomal‐coated systems. Conjugates of anticancer drugs with transferrin can significantly improve the selectivity and toxicity and overcome drug resistance, thereby leading to a better treatment. The coupling of DNA to transferrin via a polycation such as polylysine or via cationic liposomes can target and transfer of the extrogenous DNA particularly into proliferating cells through receptor‐mediated endocytosis. These kinds of non‐viral vectors are potential alternatives to viral vectors for gene therapy, if the transfection efficiency can be improved. Moreover, transferrin receptors have shown potentials in delivery of therapeutic drugs or genes into the brain across blood–brain barrier. © 2002 Wiley Periodicals, Inc. Med Res Rev, 22, No. 3, 225–250, 2002; Published online in Wiley InterScience (www.interscience.wiley.com). DOI 10.1002/med.10008
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis
Feder, J. N., Gnirke, A., Thomas, W., Tsuchihashi, Z., Ruddy, D. A., Basava, A., Dormishian, F., Domingo, R., Ellis, M. C., Fullan, A., et al. (1996) · Nature Genetics · doi:10.1038/ng0896-399 · Cited by 3,664
Cloning and characterization of a mammalian proton-coupled metal-ion transporter
Gunshin, H., Mackenzie, B., Berger, U. V., Gunshin, Y., Romero, M. F., Boron, W. F., Nussberger, S., Gollan, J. L., & Hediger, M. A. (1997) · Nature · doi:10.1038/41343 · Cited by 3,166
Andrews, N. C. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912233412607 · Cited by 2,130
THE BIOCHEMISTRY OF P-GLYCOPROTEIN-MEDIATED MULTIDRUG RESISTANCE
Endicott, J. A., & Ling, V. (1989) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.58.070189.001033 · Cited by 2,071
(2016) · CRC Press eBooks · doi:10.1201/b12801 · Cited by 2,031
Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy.
Yang, Y., Nunes, F. A., Berencsi, K., Furth, E. E., Gönczöl, E., & Wilson, J. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.10.4407 · Cited by 1,575
Hentze, M. W., & Kühn, L. C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8175 · Cited by 1,292
pH and the recycling of transferrin during receptor-mediated endocytosis.
Dautry-Varsat, A., Ciechanover, A., & Lodish, H. F. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.8.2258 · Cited by 1,179
Ogris, M., Brunner, S., Schüller, S., Kircheis, R., & Wagner, E. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300900 · Cited by 1,178
Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene
Fleming, M. D., Trenor, C. C., Su, M. A., Foernzler, D., Beier, D. R., Dietrich, W. F., & Andrews, N. C. (1997) · Nature Genetics · doi:10.1038/ng0897-383 · Cited by 1,159
Transferrin receptor on endothelium of brain capillaries
Jefferies, W. A., Brandon, M. R., Hunt, S. V., Williams, A. F., Gatter, K. C., & Mason, D. Y. (1984) · Nature · doi:10.1038/312162a0 · Cited by 1,061
Fleming, M. D., Romano, M. A., Su, M. A., Garrick, L. M., Garrick, M. D., & Andrews, N. C. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.3.1148 · Cited by 936
Non-Platinum Chemotherapeutic Metallopharmaceuticals
Clarke, M. J., Zhu, F., & Frasca, D. R. (1999) · Chemical Reviews · doi:10.1021/cr9804238 · Cited by 908
Feder, J. N., Penny, D. M., Irrinki, A., Lee, V. K., Lebrón, J. A., Watson, N., Tsuchihashi, Z., Sigal, E., Bjorkman, P. J., & Schatzman, R. C. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.4.1472 · Cited by 827
The roles of iron in health and disease
Lieu, P. T., Heiskala, M., Peterson, P. A., & Yang, Y. (2001) · Molecular Aspects of Medicine · doi:10.1016/s0098-2997(00)00006-6 · Cited by 804
The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22
Camaschella, C., Roetto, A., Calì, A., De Gobbi, M., Garozzo, G., Carella, M., Majorano, N., Totaro, A., & Gasparini, P. (2000) · Nature Genetics · doi:10.1038/75534 · Cited by 803
Global prevalence of putative haemochromatosis mutations.
Merryweather-Clarke, A. T., Pointon, J. J., Shearman, J. D., & Robson, K. J. (1997) · Journal of Medical Genetics · doi:10.1136/jmg.34.4.275 · Cited by 789
Lactoferrin: molecular structure and biological function
Lönnerdal, B., & Iyer, S. (1995) · Annual Review of Nutrition · doi:10.1146/annurev.nu.15.070195.000521 · Cited by 781
Iron-Responsive Elements: Regulatory RNA Sequences That Control mRNA Levels and Translation
Casey, J. L., Hentze, M. W., Koeller, D. M., Caughman, S. W., Rouault, T. A., Klausner, R. D., & Harford, J. B. (1988) · Science · doi:10.1126/science.2452485 · Cited by 709
The molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cells
Richardson, D. R., & Ponka, P. (1997) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/s0304-4157(96)00014-7 · Cited by 704
CRICHTON, R. R., & CHARLOTEAUX‐WAUTERS, M. (1987) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1987.tb11155.x · Cited by 686
Human cell surface glycoprotein related to cell proliferation is the receptor for transferrin.
Trowbridge, I. S., & Omary, M. B. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.5.3039 · Cited by 680
Leibold, E. A., & Munro, H. N. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.7.2171 · Cited by 671
Brain drug delivery of small molecules using immunoliposomes
Huwyler, J., Wu, D., & Pardridge, W. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.14164 · Cited by 656
Transferrin-polycation conjugates as carriers for DNA uptake into cells.
Wagner, E., Zenke, M., Cotten, M., Beug, H., & Birnstiel, M. L. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.9.3410 · Cited by 655
Molecular Cloning of Transferrin Receptor 2
Kawabata, H., Yang, R., Hirama, T., Vuong, P. T., Kawano, S., Gombart, A. F., & Koeffler, H. P. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.30.20826 · Cited by 650
Lebrón, J. A., Bennett, M. J., Vaughn, D. E., Chirino, A. J., Snow, P. M., Mintier, G. A., Feder, J. N., & Bjorkman, P. J. (1998) · Cell · doi:10.1016/s0092-8674(00)81151-4 · Cited by 638
Binding of apotransferrin to K562 cells: explanation of the transferrin cycle.
Klausner, R. D., Ashwell, G., van Renswoude, J., Harford, J. B., & Bridges, K. R. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.8.2263 · Cited by 605
Bismuth Compounds and Preparations with Biological or Medicinal Relevance
Briand, G. G., & Burford, N. (1999) · Chemical Reviews · doi:10.1021/cr980425s · Cited by 598
The physiology of transferrin and transferrin receptors.
Huebers, H. A., & Finch, C. A. (1987) · Physiological Reviews · doi:10.1152/physrev.1987.67.2.520 · Cited by 586
Ogris, M., Steinlein, P., Kursa, M., Mechtler, K., Kircheis, R., & Wagner, E. (1998) · Gene Therapy · doi:10.1038/sj.gt.3300745 · Cited by 571
Hentze, M. W., Caughman, S. W., Rouault, T. A., Barriocanal, J. G., Dancis, A., Harford, J. B., & Klausner, R. D. (1987) · Science · doi:10.1126/science.3685996 · Cited by 571
Müllner, E. W., & Kühn, L. C. (1988) · Cell · doi:10.1016/0092-8674(88)90098-0 · Cited by 554
Human lactotransferrin: amino acid sequence and structural comparisons with other transferrins
METZ-BOUTIGUE, M.-H., JOLLES, J., MAZURIER, J., SCHOENTGEN, F., LEGRAND, D., SPIK, G., MONTREUIL, J., & JOLLES, P. (1984) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1984.tb08607.x · Cited by 538
Non-platinum group metal antitumor agents. History, current status, and perspectives
Koepf-Maier, P., & Koepf, H. (1987) · Chemical Reviews · doi:10.1021/cr00081a012 · Cited by 509
Polylysine-based transfection systems utilizing receptor-mediated delivery
Zauner, W., Ogris, M., & Wagner, E. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00110-5 · Cited by 504
Müllner, E. W., Neupert, B., & Kühn, L. C. (1989) · Cell · doi:10.1016/0092-8674(89)90851-9 · Cited by 498
Metabolism and possible health effects of aluminum.
Ganrot, P. O. (1986) · Environmental Health Perspectives · doi:10.1289/ehp.8665363 · Cited by 483
Wagner, E., Zatloukal, K., Cotten, M., Kirlappos, H., Mechtler, K., Curiel, D. T., & Birnstiel, M. L. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.13.6099 · Cited by 481
Delivery of peptides and proteins through the blood–brain barrier
Bickel, U., Yoshikawa, T., & Pardridge, W. M. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00139-3 · Cited by 481
Mechanisms of Therapeutic Activity for Gallium
Bernstein, L. R. (1998) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01383-8 · Cited by 446
Aisen, P., Wessling-Resnick, M., & Leibold, E. A. (1999) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(99)80033-7 · Cited by 427
Adenovirus enhancement of transferrin-polylysine-mediated gene delivery.
Curiel, D. T., Agarwal, S., Wagner, E., & Cotten, M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.19.8850 · Cited by 423
Three-dimensional structure of diferric bovine lactoferrin at 2.8 Å resolution
Moore, S. A., Anderson, B. F., Groom, C. R., Haridas, M., & Baker, E. N. (1997) · Journal of Molecular Biology · doi:10.1006/jmbi.1997.1386 · Cited by 419
Oxidative damage in neurodegenerative disease
Jenner, P. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92347-7 · Cited by 418
Anti-transferrin receptor antibody and antibody-drug conjugates cross the blood-brain barrier.
Friden, P. M., Walus, L. R., Musso, G. F., Taylor, M. A., Malfroy, B., & Starzyk, R. M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.11.4771 · Cited by 402
Biosynthesis of nitric oxide activates iron regulatory factor in macrophages.
Drapier, J. C., Hirling, H., Wietzerbin, J., Kaldy, P., & Kühn, L. C. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb06038.x · Cited by 401
Transferrin and Transferrin Receptor Function in Brain Barrier Systems
Moos, T., & Morgan, E. H. (2000) · Cellular and Molecular Neurobiology · doi:10.1023/a:1006948027674 · Cited by 394
Structure of human lactoferrin at 3.2-A resolution.
Anderson, B. F., Baker, H. M., Dodson, E. J., Norris, G. E., Rumball, S. V., Waters, J. M., & Baker, E. N. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.7.1769 · Cited by 386
Transferrin as a Metal Ion Mediator
Sun, H., Li, H., & Sadler, P. J. (1999) · Chemical Reviews · doi:10.1021/cr980430w · Cited by 377
Self-citationMolecular structure of serum transferrin at 3.3-.ANG. resolution
Bailey, S., Evans, R. W., Garratt, R. C., Gorinsky, B., Hasnain, S., Horsburgh, C., Jhoti, H., Lindley, P. F., & Mydin, A. (1988) · Biochemistry · doi:10.1021/bi00415a061 · Cited by 365
Kircheis, R., Wightman, L., Schreiber, A., Robitza, B., Rössler, V, Kursa, M., & Wagner, E. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301351 · Cited by 350
Crystal structure of the hereditary haemochromatosis protein HFE complexed with transferrin receptor
Bennett, M. J., Lebrón, J. A., & Bjorkman, P. J. (2000) · Nature · doi:10.1038/47417 · Cited by 337
Cotten, M., Längle-Rouault, F., Kirlappos, H., Wagner, E., Mechtler, K., Zenke, M., Beug, H., & Birnstiel, M. L. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.11.4033 · Cited by 337
Parkkila, S., Waheed, A., Britton, R. S., Bacon, B. R., Zhou, X. Y., Tomatsu, S., Fleming, R. E., & Sly, W. S. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.13198 · Cited by 336
Thermodynamic binding constants for gallium transferrin
Harris, W. R., & Pecoraro, V. L. (1983) · Biochemistry · doi:10.1021/bi00271a010 · Cited by 330
Rapid responses to oxidative stress mediated by iron regulatory protein.
Pantopoulos, K., & Hentze, M. W. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07291.x · Cited by 328
Increased iron‐related MRI contrast in the substantia nigra in Parkinson's disease
Gorell, J. M., Ordidge, R. J., Brown, G. G., Deniau, J.-C., Buderer, N. M., & Helpern, J. A. (1995) · Neurology · doi:10.1212/wnl.45.6.1138 · Cited by 324
Cotten, M., Wagner, E., Zatloukal, K., Phillips, S., Curiel, D. T., & Birnstiel, M. L. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.13.6094 · Cited by 319
Crystal Structure of the Ectodomain of Human Transferrin Receptor
Lawrence, C. M., Ray, S., Babyonyshev, M., Galluser, R., Borhani, D. W., & Harrison, S. C. (1999) · Science · doi:10.1126/science.286.5440.779 · Cited by 315
Human melanoma-associated antigen p97 is structurally and functionally related to transferrin
Brown, J. P., Hewick, R. M., Hellström, I., Hellström, K. E., Doolittle, R. F., & Dreyer, W. J. (1982) · Nature · doi:10.1038/296171a0 · Cited by 290
Metal Compounds in Therapy and Diagnosis
Abrams, M. J., & Murrer, B. A. (1993) · Science · doi:10.1126/science.8102010 · Cited by 281
Coordination chemistry of metals in medicine: target sites for bismuth
Sadler, P. J., Li, H., & Sun, H. (1999) · Coordination Chemistry Reviews · doi:10.1016/s0010-8545(99)00018-1 · Cited by 280
Self-citationSequential expression of genes involved in human T lymphocyte growth and differentiation.
Krönke, M., Leonard, W. J., Depper, J. M., & Greene, W. C. (1985) · The Journal of experimental medicine · doi:10.1084/jem.161.6.1593 · Cited by 277
Wagner, E., Curiel, D., & Cotten, M. (1994) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(94)90008-6 · Cited by 275
Schneider, C., Sutherland, R., Newman, R., & Greaves, M. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)34362-x · Cited by 273
Fleming, R. E., Migas, M. C., Holden, C. C., Waheed, A., Britton, R. S., Tomatsu, S., Bacon, B. R., & Sly, W. S. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.040548097 · Cited by 273
Zenke, M., Steinlein, P., Wagner, E., Cotten, M., Beug, H., & Birnstiel, M. L. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.10.3655 · Cited by 272
Haile, D. J., Rouault, T. A., Tang, C. K., Chin, J., Harford, J. B., & Klausner, R. D. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.16.7536 · Cited by 271
ASSOCIATION OF LACTOFERRIN WITH SPECIFIC GRANULES IN RABBIT HETEROPHIL LEUKOCYTES
Baggiolini, M., de Duve, C., Masson, P. L., & Heremans, J. F. (1970) · The Journal of Experimental Medicine · doi:10.1084/jem.131.3.559 · Cited by 269
Lasic, D. D., & Templeton, N. S. (1996) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(96)00002-6 · Cited by 261
Guo, B., Yu, Y., & Leibold, E. A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)51075-4 · Cited by 258
West, A. P., Bennett, M. J., Sellers, V. M., Andrews, N. C., Enns, C. A., & Bjorkman, P. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000664200 · Cited by 257
Molecular cloning and sequence analysis of bovine lactotransferrin
PIERCE, A., COLAVIZZA, D., BENAISSA, M., MAES, P., TARTAR, A., MONTREUIL, J., & SPIK, G. (1991) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1991.tb15801.x · Cited by 253
Noninvasive gene targeting to the brain
Shi, N., & Pardridge, W. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.130187497 · Cited by 252
Pharmacokinetics and Toxicity of Bismuth Compounds
Slikkerveer, A., & Wolff, F. A. (1989) · Medical Toxicology and Adverse Drug Experience · doi:10.1007/bf03259915 · Cited by 246
Transferrin Receptor 2-α Supports Cell Growth Both in Iron-chelated Cultured Cells and in Vivo
Kawabata, H., Germain, R. S., Vuong, P. T., Nakamaki, T., Said, J. W., & Koeffler, H. P. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m908846199 · Cited by 246
Association of HFE protein with transferrin receptor in crypt enterocytes of human duodenum
Waheed, A., Parkkila, S., Saarnio, J., Fleming, R. E., Zhou, X. Y., Tomatsu, S., Britton, R. S., Bacon, B. R., & Sly, W. S. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.4.1579 · Cited by 243
Koeller, D. M., Casey, J. L., Hentze, M. W., Gerhardt, E. M., Chan, L. N., Klausner, R. D., & Harford, J. B. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.10.3574 · Cited by 243
Tabuchi, M., Yoshimori, T., Yamaguchi, K., Yoshida, T., & Kishi, F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001478200 · Cited by 238
Antitumour Metallocenes: Structure-Activity Studies and Interactions with Biomolecules.
Harding, M., & Mokdsi, G. (2000) · Current Medicinal Chemistry · doi:10.2174/0929867003374066 · Cited by 233
Gene-Delivery Systems Using Cationic Polymers
Garnett, M. C. (1999) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v16.i2.10 · Cited by 230
Qian, Z. M., & Wang, Q. (1998) · Brain Research Reviews · doi:10.1016/s0165-0173(98)00012-5 · Cited by 230
Self-citationGuo, M., Sun, H., McArdle, H. J., Gambling, L., & Sadler, P. J. (2000) · Biochemistry · doi:10.1021/bi000798z · Cited by 228
Gross, C. N., Irrinki, A., Feder, J. N., & Enns, C. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.34.22068 · Cited by 227
The G185R Mutation Disrupts Function of the Iron Transporter Nramp2
Su, M. A., Trenor, C. C., Fleming, J. C., Fleming, M. D., & Andrews, N. C. (1998) · Blood · doi:10.1182/blood.v92.6.2157 · Cited by 226
Structure and Reactivity of Transferrins
Baker, E. N. (1994) · Advances in Inorganic Chemistry · doi:10.1016/s0898-8838(08)60176-2 · Cited by 214
Possibility of active targeting to tumor tissues with liposomes
Maruyama, K., Ishida, O., Takizawa, T., & Moribe, K. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(99)00042-3 · Cited by 211
Crystal Structure of Diferric Hen Ovotransferrin at 2.4 Å Resolution
Kurokawa, H., Mikami, B., & Hirose, M. (1995) · Journal of Molecular Biology · doi:10.1006/jmbi.1995.0611 · Cited by 209
Roy, C. N., Penny, D. M., Feder, J. N., & Enns, C. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.13.9022 · Cited by 206
The binding properties of two antitumor ruthenium(III) complexes to apotransferrin.
Kratz, F., Hartmann, M., Keppler, B., & Messori, L. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)41984-3 · Cited by 204
The Primary Structure of Hen Ovotransferrin
WILLIAMS, J., ELLEMAN, T. C., KINGSTON, I. B., WILKINS, A. G., & KUHN, K. A. (1982) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1982.tb05880.x · Cited by 204
Brain iron transport and neurodegeneration
Qian, Z. M., & Shen, X. (2001) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(00)01910-9 · Cited by 197
Self-citationHallervorden-Spatz Syndrome and Brain Iron Metabolism
Swaiman, K. F. (1991) · Archives of Neurology · doi:10.1001/archneur.1991.00530240091029 · Cited by 196
Nitric Oxide and Oxidative Stress (H2O2) Control Mammalian Iron Metabolism by Different Pathways
Pantopoulos, K., Weiss, G., & Hentze, M. W. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.7.3781 · Cited by 195
Pardridge, W. M., Boado, R. J., & Kang, Y. S. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5592 · Cited by 195
Simões, S., Slepushkin, V, Gaspar, R., Pedroso de Lima, M., & Düzgüneş, N. (1998) · Gene Therapy · doi:10.1038/sj.gt.3300674 · Cited by 186
The Complete Nucleotide Sequence of the Chicken Ovotransferrin mRNA
JELTSCH, J., & CHAMBON, P. (1982) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1982.tb05879.x · Cited by 183
Lebrón, J. A., West, A. P., & Bjorkman, P. J. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.3252 · Cited by 182
A new role for the transferrin receptor in the release of iron from transferrin
Bali, P. K., Zak, O., & Aisen, P. (1991) · Biochemistry · doi:10.1021/bi00216a003 · Cited by 182
Transferrin As A Targeting Ligand for Liposomes and Anticancer Drugs
Singh, M. (1999) · Current Pharmaceutical Design · doi:10.2174/138161280506230110111312 · Cited by 181
Ligand-Receptor-Mediated Drug Delivery: An Emerging Paradigm in Cellular Drug Targeting
Vyas, S. P., Singh, A., & Sihorkar, V. (2001) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v18.i1.10 · Cited by 180
The complete amino acid sequence of human serum transferrin.
MacGillivray, R. T., Mendez, E., Sinha, S. K., Sutton, M. R., Lineback-Zins, J., & Brew, K. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.8.2504 · Cited by 178
Lactoferrin, lactoferrin receptors and iron metabolism.
Iyer, S., & Lönnerdal, B. L. (1993) · PubMed · Cited by 176
Food iron absorption in idiopathic hemochromatosis
Lynch, Sr., Skikne, B., & Cook, J. (1989) · Blood · doi:10.1182/blood.v74.6.2187.2187 · Cited by 169
Henderson, B. R., Seiser, C., & Kühn, L. C. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74253-7 · Cited by 162
Mobilization of iron from endocytic vesicles. The effects of acidification and reduction.
Núñez, M. T., Gaete, V, Watkins, J. A., & Glass, J. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)39205-1 · Cited by 159
Pharmacologic effects in vivo in brain by vector-mediated peptide drug delivery.
Bickel, U., Yoshikawa, T., Landaw, E. M., Faull, K. F., & Pardridge, W. M. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.7.2618 · Cited by 157
Serum Proteins as Drug Carriers of Anticancer Agents: A Review
Kratz, F., & Beyer, U. (1998) · Drug Delivery · doi:10.3109/10717549809065759 · Cited by 156
Salter–Cid, L., Brunmark, A. B., Li, Y., Leturcq, D., Peterson, P. A., Jackson, M. R., & Yang, Y. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5434 · Cited by 149
Chitambar, C., Matthaeus, W., Antholine, W. E., Graff, K. E., & O'Brien, W. (1988) · Blood · doi:10.1182/blood.v72.6.1930.1930 · Cited by 148
Luigi Messori, A., Orioli, P., Vullo, D., Alessio, E., & Iengo, E. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01121.x · Cited by 143
Citro, G., Perrotti, D., Cucco, C., D’Agnano, I., Sacchi, A., Zupi, G., & Calabretta, B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.15.7031 · Cited by 143
Dewan, J. C., Mikami, B., Hirose, M., & Sacchettini, J. C. (1993) · Biochemistry · doi:10.1021/bi00096a004 · Cited by 140
Transcriptional Regulation by Iron of the Gene for the Transferrin Receptor
Rao, K., Harford, J. B., Rouault, T. A., McClelland, A., Ruddle, F. H., & Klausner, R. D. (1986) · Molecular and Cellular Biology · doi:10.1128/mcb.6.1.236 · Cited by 128
Constable, A., Quick, S., Gray, N. K., & Hentze, M. W. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.10.4554 · Cited by 127
Unexpectedly Strong Binding of a Large Metal Ion (Bi3+) to Human Serum Transferrin
Li, H., Sadler, P. J., & Sun, H. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.16.9483 · Cited by 123
Self-citationKordower, J. H., Charles, V., Bayer, R. A., Bartus, R. T., Putney, S. D., Walus, L. R., & Friden, P. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.19.9077 · Cited by 116
Transferrin, the transferrin receptor, and the uptake of iron by cells.
Aisen, P. (1998) · PubMed · Cited by 115
Chitambar, C. R., & Zivkovic, Z. (1987) · PubMed · Cited by 114
Regulation of transferrin receptors in human hematopoietic cell lines.
Louache, F., Testa, U., Pelicci, P. G., THOMOPOULOS, P., Titeux, M., & Rochant, H. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)90901-4 · Cited by 112
Mechanisms of iron uptake by mammalian cells
Qian, Z., & Tang, P. L. (1995) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(95)00098-x · Cited by 107
Self-citationBhasker, C. R., Burgiel, G., Neupert, B., Emery-Goodman, A., Kühn, L. C., & May, B. K. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)31444-3 · Cited by 104
Equilibrium Constants for the Binding of Indium(III) to Human Serum Transferrin
Harris, W. R., Chen, Y., & Wein, K. (1994) · Inorganic Chemistry · doi:10.1021/ic00100a024 · Cited by 103
Hypoglycemic Effect of Insulin-Transferrin Conjugate in Streptozotocin-Induced Diabetic Rats
Xia, C. Q., Wang, J., & Shen, W. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38943-8 · Cited by 103
The Biological and Medicinal Chemistry of Bismuth
Sun, H., Li, H., & Sadler, P. J. (1997) · Chemische Berichte · doi:10.1002/cber.19971300602 · Cited by 102
Self-citationPenichet, M. L., Kang, Y., Pardridge, W. M., Morrison, S. L., & Shin, S.-U. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.8.4421 · Cited by 100
Differential Modulation of the RNA-binding Proteins IRP-1 and IRP-2 in Response to Iron
Henderson, B. R., & Kühn, L. C. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.35.20509 · Cited by 96
Powell, L. W., Campbell, C. B., & Wilson, E. (1970) · Gut · doi:10.1136/gut.11.9.727 · Cited by 96
Yamagata, M., & Tannock, I. F. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.254 · Cited by 95
Seiser, C., Teixeira, S. M. R., & Kühn, L. C. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)38621-1 · Cited by 92
Lebrón, J. A., & Björkman, P. J. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.2842 · Cited by 92
Inhibition of ribonucleotide reductase by gallium in murine leukemic L1210 cells.
Chitambar, C. R., Narasimhan, J., Guy, J., Sem, D. S., & O'Brien, W. J. (1991) · PubMed · Cited by 92
Xu, L., Pirollo, K. F., & Chang, E. H. (1997) · Human Gene Therapy · doi:10.1089/hum.1997.8.4-467 · Cited by 88
Distribution of iron in different brain regions and subcellular compartments in Parkinson's disease
Riederer, P. F., Dirr, A., Goetz, M. E., Sofic, E., Jellinger, K. A., & Youdimt, M. B. H. (1992) · Annals of Neurology · doi:10.1002/ana.410320717 · Cited by 88
Regulation of intestinal non-haem iron absorption.
Lombard, M., Chua, E., & O’Toole, P. (1997) · Gut · doi:10.1136/gut.40.4.435 · Cited by 84
67Ga binding to human serum proteins and tumor components.
Clausen, J., Edeling, C.-J., & Fogh, J. (1974) · PubMed · Cited by 84
Expression of cloned human lactoferrin in baby-hamster kidney cells
Stowell, K. M., Rado, T. A., Funk, W. D., & Tweedie, J. W. (1991) · Biochemical Journal · doi:10.1042/bj2760349 · Cited by 84
Bismuth(III) Complexes of the Tripeptide Glutathione (γ‐L‐Glu–L‐Cys–Gly)
Sadler, P. J., Sun, H., & Li, H. (1996) · Chemistry - A European Journal · doi:10.1002/chem.19960020615 · Cited by 82
Self-citationEndogenous carriers and ligands in non-immunogenic site-specific drug delivery
Vyas, S. P., & Sihorkar, V. (2000) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00067-3 · Cited by 82
de Lima, M. C. P., de Lima, Simões, S., Pires, P., Gaspar, R. S., Slepushkin, V., & Düzgüneş, N. (1999) · Molecular Membrane Biology · doi:10.1080/096876899294823 · Cited by 81
Synthesis and in Vitro Efficacy of Transferrin Conjugates of the Anticancer Drug Chlorambucil
Beyer, U., Roth, T. F., Schumacher, P. M., et al. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm9704661 · Cited by 80
Yoshikawa, T., & Pardridge, W. M. (1992) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10429-1 · Cited by 78
Transferrin receptors of human fibroblasts. Analysis of receptor properties and regulation
Ward, J. H., Kushner, J. P., & Kaplan, J. (1982) · Biochemical Journal · doi:10.1042/bj2080019 · Cited by 75
Bezkorovainy, A. (1981) · Springer eBooks · doi:10.1007/978-1-4684-3779-9 · Cited by 73
Transferrin conjugates of adriamycin are cytotoxic without intercalating nuclear DNA.
Barabás, K., SIZENSKY, J. A., & Faulk, W. P. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50442-2 · Cited by 71
Pelosi, E., Testa, U., Louache, F., THOMOPOULOS, P., Salvo, G., Samoggia, P., & Peschle, C. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)35742-3 · Cited by 70
DUBLJEVIC, V., SALI, A., & GODING, J. W. (1999) · Biochemical Journal · doi:10.1042/0264-6021:3410011 · Cited by 63
Enhanced antimicrobial activity of lactoferrin by binding to the bacterial surface.
Dalmastri, C., Valenti, P., Visca, P., Vittorioso, P., & Orsi, N. (1988) · PubMed · Cited by 63
Primary receptor-recognition site of human transferrin is in the C-terminal lobe.
Zak, O., Trinder, D., & Aisen, P. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37254-x · Cited by 63
Li, J. Y., Sugimura, K., Boado, R. J., Lee, H., Zhang, C., Dübel, S., & Pardridge, W. M. (1999) · Protein Engineering Design and Selection · doi:10.1093/protein/12.9.787 · Cited by 63
Competitive Binding of Bismuth to Transferrin and Albumin in Aqueous Solution and in Blood Plasma
Sun, H., Li, H., Mason, A. B., Woodworth, R. C., & Sadler, P. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m004779200 · Cited by 61
Self-citationBacterial Lactoferrin Receptors
Schryvers, A. B., Bonnah, R. A., Yu, R., Wong, H., & Retzer, M. D. (1998) · Advances in experimental medicine and biology · doi:10.1007/978-1-4757-9068-9_15 · Cited by 60
Wang, F., Jiang, X., Yang, D., et al. (2000) · PubMed · Cited by 58
Faber, R. H., Bland, T., Day, C. L., Norris, G. E., Tweedie, J. W., & Baker, E. N. (1996) · Journal of Molecular Biology · doi:10.1006/jmbi.1996.0091 · Cited by 58
Luigi Messori, A., Orioli, P., Banholzer, V., Pais, I., & Zatta, P. F. (1999) · FEBS Letters · doi:10.1016/s0014-5793(98)01651-2 · Cited by 56
Receptor recognition sites reside in both lobes of human serum transferrin
Mason, A. B., Tam, B. M., Woodworth, R. C., Oliver, R. W. A., Green, B. N., Lin, L., Brandts, J. F., Savage, K. J. J., Lineback, J. A., & MacGillivray, R. T. A. (1997) · Biochemical Journal · doi:10.1042/bj3260077 · Cited by 54
Zhang, L., Szeto, K.-Y., Wong, W. B., Loh, T. T., Sadler, P. J., & Sun (2001) · Biochemistry · doi:10.1021/bi010579t · Cited by 53
Novel gene delivery systems: complexes of fusigenic polymer-modified liposomes and lipoplexes
Kono, K., Torikoshi, Y., Mitsutomi, M., Itoh, T., Emi, N., Yanagië, H., & Takagishi, T. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301365 · Cited by 53
Receptor-mediated Transport of Therapeutics across the Blood-Brain Barrier
Friden, P. M. (1994) · Neurosurgery · doi:10.1227/00006123-199408000-00016 · Cited by 45
Killing of human tumor cells in culture with adriamycin conjugates of human transferrin
Yeh, C. G., & Faulk, W. P. (1984) · Clinical Immunology and Immunopathology · doi:10.1016/0090-1229(84)90037-0 · Cited by 44
Resistance to bismuth among Gram-negative bacteria is dependent upon iron and its uptake
Domenico, P., Reich, J., Madonia, W., & Cunha, B. A. (1996) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/38.6.1031 · Cited by 44
Sun, H., Cox, M. C., Li, H., Mason, A. B., Woodworth, R. C., & Sadler, P. J. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00034-9 · Cited by 43
Self-citationCytotoxic effects of a doxorubicin-transferrin conjugate in multidrug-resistant KB cells
Fritzer, M., Szekeres, T., Szüts, V., Jarayam, H. N., & Goldenberg, H. (1996) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)02225-2 · Cited by 43
The crystal structure of monoferric human serum transferrin
Zuccola, H. J. (1992) · SMARTech Repository (Georgia Institute of Technology) · Cited by 42
Walus, L. R., Pardridge, W. M., Starzyk, R. M., & Friden, P. M. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12894-2 · Cited by 41
Basilion, J. P., Kennedy, M. C., Beinert, H., Massinople, C. M., Klausner, R. D., & Rouault, T. A. (1994) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1994.1270 · Cited by 41
Binding and transport of nonferrous metals by serum transferrin
Harris, W. R. (2006) · Springer eBooks · doi:10.1007/bfb0081079 · Cited by 39
Tsuchiya, Y., Nakao, A., Komatsu, T., Yamamoto, M., & Shimokata, K. (1992) · CHEST Journal · doi:10.1378/chest.102.2.530 · Cited by 39
N-lobe versus C-lobe complexation of bismuth by human transferrin
Sun, H., Hongyan, L. I., Mason, A. B., Woodworth, R. C., & Sadler, P. J. (1998) · Biochemical Journal · doi:10.1042/bj3370105 · Cited by 38
Self-citationDemonstration and Characterization of the Iron Regulatory Protein in Human Brain
Hu, J., & Connor, J. R. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.67020838.x · Cited by 37
Buchegger, F., Trowbridge, I. S., Liu, L. S., White, S., & Collawn, J. F. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.0009u.x · Cited by 37
Ouyang, Q., Bommakanti, M., & Miskimins, W. K. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.3.1796-1804.1993 · Cited by 37
Yanagihara, K., Cheng, H., & Cheng, P. (2000) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700092 · Cited by 36
Adriamycin Conjugates of Human Transferrin Bind Transferrin Receptors and Kill K562 and HL60-Cells
Berczi, A., Barabás, K., SIZENSKY, J. A., et al. (1993) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1993.1048 · Cited by 35
Beamish, M. R., & Brown, E. B. (1974) · Blood · doi:10.1182/blood.v43.5.703.703 · Cited by 33
An alternative model for the binding and release of diferric transferrin by reticulocytes
Woodworth, R. C., Brown, A. S., Christensen, T. G., Witt, D. P., & Comeau, R. D. (1982) · Biochemistry · doi:10.1021/bi00261a005 · Cited by 33
Anderson, G. J. (1996) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.1996.tb00029.x · Cited by 30
Factors affecting the binding of gallium-67 in serum
Tsan, M., Scheffel, U., Tzen, K., & Camargo, E. E. (1980) · International Journal of Nuclear Medicine and Biology · doi:10.1016/0047-0740(80)90107-2 · Cited by 28
Bérczi, A., Ruthner, M., Szüts, V., Fritzer, M., Schweinzer, E., & Goldenberg, H. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb17778.x · Cited by 28
Ali, S. A., João, H. C., Hammerschmid, F., Eder, J., & Steinkasserer, A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.34.24066 · Cited by 26
Transport of 67Ga and 111In across a membrane. Role of plasma binding and concentration gradients
Raijmakers, P. G. H. M., Groeneveld, A. B. J., den Hollander, W., & Teule, G. J. J. (1992) · Nuclear Medicine Communications · doi:10.1097/00006231-199205000-00009 · Cited by 25
Mechanism of action and spectrum of cell lines sensitive to a doxorubicin-transferrin conjugate
Lai, B.-T., Gao, J., & Lanks, K. W. (1997) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800050722 · Cited by 25
Testa, E. P., Testa, U., Samoggia, P., Salvo, G., CAMAGNA, A., & Peschle, C. (1986) · PubMed · Cited by 24
Hemochromatosis: Genetics and Pathogenesis
Powell, L. W., Burt, M., Halliday, J. W., & Jazwinska, E. C. (1996) · Seminars in Liver Disease · doi:10.1055/s-2007-1007219 · Cited by 23
Hatano, T., Ohkawa, K., & Matsuda, M. (1993) · Tumor Biology · doi:10.1159/000217841 · Cited by 22
Hege, K., Daleke, D. L., Waldmann, T. A., & Matthay, K. K. (1989) · Blood · doi:10.1182/blood.v74.6.2043.2043 · Cited by 21
Pumping iron in Parkinson's disease
Bonn, D. (1996) · The Lancet · doi:10.1016/s0140-6736(96)91094-6 · Cited by 20
Tanaka, T., Fujishima, Y., & Kaneo, Y. (2001) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.24.268 · Cited by 18
Production and Characterization of Fusion Proteins Containing Transferrin and Nerve Growth Factor
Park, E.-C., Starzyk, R. M., McGrath, J. P., Lee, T., George, J., Schutz, A. J., Lynch, P., & Putney, S. D. (1998) · Journal of drug targeting · doi:10.3109/10611869808997881 · Cited by 16
Chemistry and Metabolism of the Transferrins
Bezkorovainy, A. (1980) · Springer eBooks · doi:10.1007/978-1-4684-3779-9_4 · Cited by 14
Weiner, R. E., Avis, I. M., Neumann, R. D., & Mulshine, J. L. (1996) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240630523 · Cited by 14
Liao, W.-P., DeHaven, J. I., Shao, J., Chen, J., Rojanasakul, Y., Lamm, D. L., & Ma, J. K. H. (1998) · Drug Delivery · doi:10.3109/10717549809031386 · Cited by 7
Receptor-mediated Transport of Therapeutics across the Blood-Brain Barrier
Friden, P. M. (1994) · Neurosurgery · doi:10.1097/00006123-199408000-00016 · Cited by 5
In vivo compatibility and degradation of crosslinked gelatin gels incorporated in knitted Dacron
(2000) · Pure Amsterdam UMC · doi:10.1002/(sici)1097-4636(200007)51:1 · Cited by 4
Cited by
Tenchov, R., Bird, R., Curtze, A. E., & Zhou, Q. (2021) · ACS Nano · doi:10.1021/acsnano.1c04996 · Cited by 2,221
Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy
Pérez-Herrero, E., & Fernández-Medarde, A. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.03.018 · Cited by 1,875
Advanced materials and processing for drug delivery: The past and the future
Zhang, Y., Chan, H. F., & Leong, K. W. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.10.003 · Cited by 1,000
New metal complexes as potential therapeutics
Zhang, C. X., & Lippard, S. J. (2003) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(03)00081-4 · Cited by 946
Targeted delivery of low molecular drugs using chitosan and its derivatives
Park, J. H., Saravanakumar, G., Kim, K., & Kwon, I. C. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.10.003 · Cited by 821
Metadata
- Authors
- Li, H., & Qian, Z. M.
- Venue
- Medicinal Research Reviews
- Publisher
- Wiley
- Published
- 2002-03-26
- Volume
- 22
- Issue
- 3
- Pages
- 225-250
- ISSN
- 0198-6325 (ISSN-L)
- 1098-1128
- OpenAlex
- W3099031341
- Cited by
- 441
- References
- 195
- FWCI
- 4.05
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.